Filtration as the main mechanism of increased protein extravasation in liver cirrhosis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Filtration as the main mechanism of increased protein extravasation in liver cirrhosis. / Henriksen, Jens Henrik Sahl; Parving, H H; Lassen, N A; Winkler, K.

In: Scandinavian Journal of Clinical & Laboratory Investigation, Vol. 40, No. 2, 1980, p. 121-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Henriksen, JHS, Parving, HH, Lassen, NA & Winkler, K 1980, 'Filtration as the main mechanism of increased protein extravasation in liver cirrhosis', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 40, no. 2, pp. 121-8.

APA

Henriksen, J. H. S., Parving, H. H., Lassen, N. A., & Winkler, K. (1980). Filtration as the main mechanism of increased protein extravasation in liver cirrhosis. Scandinavian Journal of Clinical & Laboratory Investigation, 40(2), 121-8.

Vancouver

Henriksen JHS, Parving HH, Lassen NA, Winkler K. Filtration as the main mechanism of increased protein extravasation in liver cirrhosis. Scandinavian Journal of Clinical & Laboratory Investigation. 1980;40(2):121-8.

Author

Henriksen, Jens Henrik Sahl ; Parving, H H ; Lassen, N A ; Winkler, K. / Filtration as the main mechanism of increased protein extravasation in liver cirrhosis. In: Scandinavian Journal of Clinical & Laboratory Investigation. 1980 ; Vol. 40, No. 2. pp. 121-8.

Bibtex

@article{118ff8704e1211df928f000ea68e967b,
title = "Filtration as the main mechanism of increased protein extravasation in liver cirrhosis",
abstract = "Transvascular escape rates of albumin and immunoglobulin-G, IgG (TERalb and TERIgG, i.e, the fractions of intravascular mass of albumin and IgG passing to the extravascular space per unit time) were determined simultaneously from the disappearance of intravenously injected 131I-labelled human serum albumin and 125I-labelled human IgG in eight patients with cirrhosis of the liver. The mean wedged hepatic venous pressure was 22 mmHg (range 13-34). TERalb and and TERIgG/TERalb ratio was on average 8.4 +/- 0.8%/h (SD), and 7.4 +/- 1.9%/h (SD), respectively and these values are significantly increased compared to normal subjects [TERalb = 5.2 +/- 1.0 %/h (SD) and TERIgG = 3.0 +/- 0.7 %/h (SD), P less than 0.001]. The TERIgG/TERalb ratio was on average 0.88 +/- 0.20 (SD), which is significantly higher than that of normals [0.58 +/- 0.08 (SD), P less than 0.005]. The results indicated that increased filtration (bulk flow) is the dominant process of the increase microvascular protein escape in cirrhosis, due most likely to increased hepatic, but also to increased extrahepatic splanchnic transcapillary protein flux.",
author = "Henriksen, {Jens Henrik Sahl} and Parving, {H H} and Lassen, {N A} and K Winkler",
note = "Keywords: Adult; Aged; Capillary Permeability; Female; Humans; Immunoglobulin G; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Models, Biological; Proteins; Serum Albumin; Serum Albumin, Radio-Iodinated",
year = "1980",
language = "English",
volume = "40",
pages = "121--8",
journal = "Scandinavian Journal of Clinical & Laboratory Investigation",
issn = "0036-5513",
publisher = "Taylor & Francis",
number = "2",

}

RIS

TY - JOUR

T1 - Filtration as the main mechanism of increased protein extravasation in liver cirrhosis

AU - Henriksen, Jens Henrik Sahl

AU - Parving, H H

AU - Lassen, N A

AU - Winkler, K

N1 - Keywords: Adult; Aged; Capillary Permeability; Female; Humans; Immunoglobulin G; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Models, Biological; Proteins; Serum Albumin; Serum Albumin, Radio-Iodinated

PY - 1980

Y1 - 1980

N2 - Transvascular escape rates of albumin and immunoglobulin-G, IgG (TERalb and TERIgG, i.e, the fractions of intravascular mass of albumin and IgG passing to the extravascular space per unit time) were determined simultaneously from the disappearance of intravenously injected 131I-labelled human serum albumin and 125I-labelled human IgG in eight patients with cirrhosis of the liver. The mean wedged hepatic venous pressure was 22 mmHg (range 13-34). TERalb and and TERIgG/TERalb ratio was on average 8.4 +/- 0.8%/h (SD), and 7.4 +/- 1.9%/h (SD), respectively and these values are significantly increased compared to normal subjects [TERalb = 5.2 +/- 1.0 %/h (SD) and TERIgG = 3.0 +/- 0.7 %/h (SD), P less than 0.001]. The TERIgG/TERalb ratio was on average 0.88 +/- 0.20 (SD), which is significantly higher than that of normals [0.58 +/- 0.08 (SD), P less than 0.005]. The results indicated that increased filtration (bulk flow) is the dominant process of the increase microvascular protein escape in cirrhosis, due most likely to increased hepatic, but also to increased extrahepatic splanchnic transcapillary protein flux.

AB - Transvascular escape rates of albumin and immunoglobulin-G, IgG (TERalb and TERIgG, i.e, the fractions of intravascular mass of albumin and IgG passing to the extravascular space per unit time) were determined simultaneously from the disappearance of intravenously injected 131I-labelled human serum albumin and 125I-labelled human IgG in eight patients with cirrhosis of the liver. The mean wedged hepatic venous pressure was 22 mmHg (range 13-34). TERalb and and TERIgG/TERalb ratio was on average 8.4 +/- 0.8%/h (SD), and 7.4 +/- 1.9%/h (SD), respectively and these values are significantly increased compared to normal subjects [TERalb = 5.2 +/- 1.0 %/h (SD) and TERIgG = 3.0 +/- 0.7 %/h (SD), P less than 0.001]. The TERIgG/TERalb ratio was on average 0.88 +/- 0.20 (SD), which is significantly higher than that of normals [0.58 +/- 0.08 (SD), P less than 0.005]. The results indicated that increased filtration (bulk flow) is the dominant process of the increase microvascular protein escape in cirrhosis, due most likely to increased hepatic, but also to increased extrahepatic splanchnic transcapillary protein flux.

M3 - Journal article

C2 - 7256180

VL - 40

SP - 121

EP - 128

JO - Scandinavian Journal of Clinical & Laboratory Investigation

JF - Scandinavian Journal of Clinical & Laboratory Investigation

SN - 0036-5513

IS - 2

ER -

ID: 19398545